Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-11-02 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including consolidated income statements for the third quarter of the year 112 (Taiwan calendar), with comparisons to the previous year. It includes comprehensive financial figures such as revenue, costs, gross profit, operating expenses, net income, earnings per share, and other detailed financial metrics. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3056 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-11-02 Chinese
112年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 112年09月30日 (September 30, 2023) and 111年12月31日 (December 31, 2022). It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, and equity. The presence of actual financial figures and the nature of the content indicate this is a financial report for a period shorter than a full fiscal year (quarterly data). The document length is 4015 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-11-02 Chinese
公告本公司一針劑型透明質酸”Hyaflex-forte(Synovial Fluid Pre-Filled Syringe) ”及三針劑型”Hyaflex(Synovial Fluid Supplement) ”關節腔注射劑產品取得銷售許可證書。
Regulatory Filings Classification · 95% confidence The document is a short announcement (1004 characters) from a listed company (科妍生物科技股份有限公司) reporting the receipt of sales permits for certain medical products. It includes factual details such as the event date, product description, and impact on company revenue. There is no financial data, no detailed report, no management discussion, or regulatory certification. The document is a regulatory announcement about a material event affecting the company but does not constitute a financial report or detailed filing. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-10-26 Chinese
112年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous month, with zero balances reported. The content is concise, factual, and does not contain detailed financial statements or analysis. It appears to be a regulatory disclosure related to financial guarantees and loans, typical of a regulatory filing rather than a full report or announcement. The document length is short (601 characters), and it does not indicate it is an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-10-06 Chinese
112年9月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary revenue report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards and reporting requirements but does not contain comprehensive financial statements or detailed analysis. The document length is short (769 characters) and it appears to be a regulatory disclosure of financial data rather than a full financial report. It is not an announcement of a report publication but a brief financial summary. This fits best with the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-10-06 Chinese
公告本公司婦產科用產品麗復達可吸收防沾黏凝膠取得 中華民國衛生福利部(TFDA)核發第三類醫材銷售許可證
Regulatory Filings Classification · 95% confidence The document is a short announcement (872 characters) from a company named 科妍生物科技股份有限公司 about obtaining a medical device sales permit from the Taiwan Food and Drug Administration (TFDA). It is a regulatory disclosure about a product approval, not a financial report or detailed management discussion. It does not contain financial statements, earnings data, or detailed report content. It is a regulatory announcement about a material event affecting the company, fitting the category of Regulatory Filings (RNS).
2023-10-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.